Synthesis and Evaluation of Quinazolin‐4(3 <i>H</i> )‐one Derivatives as Multitarget Metabolic Enzyme Inhibitors: A Biochemistry‐Oriented Drug DesignFeyzi Sinan Tokalı, Halil Şenol, Parham Taslımı et al.|ChemistrySelect|2023Cited by 54
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studiesFeyzi Sinan Tokalı, Ebru Hacıosmanoğlu, Halil Şenol et al.|Archiv der Pharmazie|2023Cited by 53
Exploring highly selective polymethoxy fenamate isosteres as novel anti-prostate cancer agents: Synthesis, biological activity, molecular docking, molecular dynamics, and ADME studiesFeyzi Sinan Tokalı, Fahri Akbaş, Halil Şenol et al.|Journal of Molecular Structure|2024Cited by 48
Synthesis, characterization and molecular docking studies of highly selective new hydrazone derivatives of anthranilic acid and their ring closure analogue Quinazolin-4(3H)-ones against lung cancer cells A549Feyzi Sinan Tokalı, Ebru Hacıosmanoğlu, Halil Şenol et al.|Journal of Molecular Structure|2023Cited by 45
New Anthranilic Acid Hydrazones as Fenamate Isosteres: Synthesis, Characterization, Molecular Docking, Dynamics & <i>in Silico</i> ADME, <i>in Vitro</i> Anti‐Inflammatory and Anticancer Activity StudiesHalil Şenol, Feyzi Sinan Tokalı, Zeynep Çağman et al.|Chemistry & Biodiversity|2023Cited by 44